Vir Biotechnology, Inc.

Vir Biotechnology is a drug development company working on treatments for serious infectious diseases and certain cancers. The company is still in the early stages of testing its medicines and has not yet brought any to market. It partners with other pharmaceutical and research organizations to develop therapies targeting diseases like hepatitis delta virus, influenza, coronavirus, and solid tumors. The company was founded in 2016 and is based in San Francisco.